BioPharmSignal logoBioPharmSignal

Biotech News

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

Bluejay Diagnostics (BJDX)Bluejay DiagnosticsEarnings

ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (“Bluejay” or the “Company”), a medical diagnostics company focused on improving patient outcomes in critical care settings, today provided a corporate update highlighting progress achieved during the first quarter of 2026 and

Related news

BJDXBluejay Diagnostics2026-08-13 10:00 EST

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

LUCDLucid Diagnostics2026-05-14 12:00 EST

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

LUCDLucid Diagnostics2026-04-30 12:31 EST

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

DGXQuest Diagnostics2026-04-21 10:47 EST

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

DGXQuest Diagnostics2026-03-19 14:00 EST

Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026

BJDXBluejay Diagnostics2026-03-06 11:30 EST

Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook

XGNExagen2026-05-11 12:00 EST

Exagen Inc. Reports First Quarter 2026 Results

OSUROraSure Technologies, Inc.2026-05-06 20:05 EST

OraSure Announces First Quarter 2026 Financial Results

MDXHMDxHealth2026-04-30 20:00 EST

Mdxhealth to Release First Quarter 2026 Financial Results on May 13

XGNExagen2026-04-27 13:00 EST

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

View all latest news

Bluejay Diagnostics

Critical-Care Diagnostics Bluejay Diagnostics develops rapid blood tests for hospital and critical-care settings using its Symphony diagnostic platform. Symphony Platform Symphony is an automated, near-patient testing system designed to provide quantitative biomarker results without relying on a central laboratory workflow. Symphony IL-6...

Recent company news

BJDXBluejay Diagnostics2026-08-13 10:00 EST

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

BJDXBluejay Diagnostics2026-07-21 10:30 EST

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

BJDXBluejay Diagnostics2026-06-06 00:13 EST

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

BJDXBluejay Diagnostics2026-06-02 16:19 EST

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

BJDXBluejay Diagnostics2026-06-02 10:30 EST

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

Stock data

Close
1.02 USD
Market cap
4.49M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States